Journals / Eurasian Journal of Emergency Medicine / 2019 / Cilt: 18 - Sayı: 2

Investigation of the Clinical Course and Outcomes of Bonsai Use

Pages
72–78
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Intoxication was correlated with creatinine and creatinekinase-myocardial band (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: We aimed to contribute to the contemporary literature by investigating the clinical course and outcomes of bonsai, a syntheticcannabinoid with progressively increasing use.Materials and Methods: Our study retrospectively reviewed the medical records of 149 patients with symptoms related to bonsai use.
📊
Key Findings & Data:Theparameters included age, gender, blood pressure, heart rate, respiratory rate, body temperature, Glasgow coma scale, route and durationof bonsai use, time used, symptoms, follow-up period in the emergency department, regular ward and intensive care unit, need formechanical ventilation, biochemistry panel, abstinence, intoxication, mortality, and morbidity.Results: The most common symptoms were agitation (49.7%) and anxiety (28.9%).
💡
Conclusion & Impact:Intoxication was correlated with creatinine and creatinekinase-myocardial band (p
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: We aimed to contribute to the contemporary literature by investigating the clinical course and outcomes of bonsai, a syntheticcannabinoid with progressively increasing use.Materials and Methods: Our study retrospectively reviewed the medical records of 149 patients with symptoms related to bonsai use. Theparameters included age, gender, blood pressure, heart rate, respiratory rate, body temperature, Glasgow coma scale, route and durationof bonsai use, time used, symptoms, follow-up period in the emergency department, regular ward and intensive care unit, need formechanical ventilation, biochemistry panel, abstinence, intoxication, mortality, and morbidity.Results: The most common symptoms were agitation (49.7%) and anxiety (28.9%). Intoxication was correlated with creatinine and creatinekinase-myocardial band (p

🔖

Cite This Article

DOĞAN, B., KAVAK, N., ÇAVUŞ, U. Y., KAVAK, R. P., SULTANOĞLU, H. (2022). Investigation of the Clinical Course and Outcomes of Bonsai Use. Eurasian Journal of Emergency Medicine, Cilt: 18 - Sayı: 2, 72–78. https://ajindex.com/articles/508000

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Orsini J, Blaak C, Tam E, Rajayer S, Morante J, Yeh A, et al. The wide and unpredictable scope of synthetic cannabinoids toxicity. Case Rep Crit Care. 2015;2015:542490
  2. Artuç S, Doğan KH, Demirci Ş. Uyuşturucu maddelerde yeni trend: sentetik kannabinoidler. Adli Tıp Bülteni. 2014;19:198-203
  3. Doğan H, Özüçelik DN, Açıksarı K, Avcı A, Yazıcığlu M, Çelikmen MF, et al. New synthetic cannabinoid intoxications in emergency department (It’s grass, it’s no sin). Anadolu Psikiyatri Derg. 2016;17:18-25
  4. Aoun EG, Christopher PP, Ingraham JW. Emerging drugs of use: clinical and legal considerations. RI Med J (2013). 2014;97:41-5
  5. Office of National Drug Control Policy. (2014). Fact sheet: Synthetic drugs (a.k.a. K2, Spice, bath salts, etc.). http://www.whitehouse.gov/ondcp/ondcpfact- sheets/synthetic-drugs-k2-spice-bath-salts Son erişim tarihi:01.01.2017
  6. Hudson S, Ramsey J, King L, Timbers S, Maynard S, Dargan PI, et al. Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in “herbal high” products. J Anal Toxicol. 2010;34:252-60
  7. Küçük E, Küçük İ, Kirazaldı YY. Acil serviste yeni bir tehlike: Sentetik kannabinoidler (Bonsai, Jameika). Genel Tıp Derg. 2015;25:18-22
  8. Freeman MJ, Rose DZ, Myers MA, Gooch CL, Bozeman AC, Burgin WS. Ischemic stroke after use of the synthetic marijuana “spice”. Neurology. 2013;81:2090-3
  9. Thornton SL, Wood C, Friesen MW, Gerona RR. Synthetic cannabinoid use associated with acute kidney injury. Clin Toxicol (Phila). 2013;51:189-90
  10. McKeever RG, Vearrier D, Jacobs D, LaSala G, Okaneku J, Greenberg MI. K2- -not the spice of life; synthetic cannabinoids and ST elevation myocardial infarction: a case report. J Med Toxicol. 2015;11:129-31
  11. Eminler AT, Yıldırım M, Uslan Mİ, Köksal AŞ, Parlak E. Sentetik kannabinoidler (BONZAİ) ve gastrointestinal sistem üzerine etkileri: “Kannabinoid Hiperemezis Sendromu”. Güncel Gastroentereloji. 2014;18:460-3
  12. Atik SU, Dedeoğlu R, Varol F, Çam H, Eroğlu AG, Saltık L. Cardiovascular side effects related with use of synthetic cannabinoids “bonzai”: two case reports. Turk Pediatri Ars. 2015;50:61-4
  13. EMCDDA 2013 Ulusal Raporu (2012 Verileri) Reitox Ulusal Temas Noktası. Türkiye Uyuşturucu Ve Uyuşturucu Bağımlılığı İzleme Merkezi (TUBİM) Ankara 2013
  14. Bozkurt M, Umut G, Evren C, Karabulut V. Sentetik kannabinoid kullanımı nedeniyle polikliniğe başvuran hastaların klinik özellikleri ve laboratuvar sonuçları. Düşü